Omics data integration facilitates target selection for new antiparasitic drugs against TriTryp infections
Introduction:Trypanosoma cruzi, Trypanosoma brucei, and Leishmania spp., commonly referred to as TriTryps, are a group of protozoan parasites that cause important human diseases affecting millions of people belonging to the most vulnerable populations worldwide. Current treatments have limited effic...
Main Authors: | Martin Rivara-Espasandín, Miranda Clara Palumbo, Ezequiel J. Sosa, Santiago Radío, Adrián G. Turjanski, José Sotelo-Silveira, Dario Fernandez Do Porto, Pablo Smircich |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1136321/full |
Similar Items
-
Revisiting the functional annotation of TriTryp using sequence similarity tools
by: Poorya Mirzavand Borujeni, et al.
Published: (2024-10-01) -
Current Status of Regulatory Non-Coding RNAs Research in the Tritryp
by: Rafael Sebastián Fort, et al.
Published: (2022-07-01) -
The TriTryp Phosphatome: analysis of the protein phosphatase catalytic domains
by: Huxley-Jones Julie, et al.
Published: (2007-11-01) -
Upstream ORFs Influence Translation Efficiency in the Parasite Trypanosoma cruzi
by: Santiago Radío, et al.
Published: (2020-02-01) -
Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis
by: Laura M. Alcântara, et al.
Published: (2018-12-01)